Scientific Publications

Advancing dermatological science.

March 2024

AAD 2024

Roflumilast Foam 0.3% Once Daily in Patients With Seborrheic Dermatitis: Improvement in Patient-Reported Outcomes and Pruritus From a Phase 3 Trial (STRATUM)

October 2023

Br J Dermatol

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study

May 2023

JAMA Dermatology

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial

March 2023

AAD 2023

Efficacy and Safety of Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results From the DERMIS-1 and DERMIS-2 Phase 3 Trials

March 2023

AAD 2023

Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus

March 2023

AAD 2023

Patient and Healthcare Provider Perspectives on the Path to Diagnosis of Seborrheic Dermatitis: Results From a National Survey of Adults With Seborrheic Dermatitis in the United States

March 2023

AAD 2023

Patient and Healthcare Provider Perspective on the Disease Burden of Seborrheic Dermatitis in the United States: Results from a National Survey

March 2023

AAD 2023

Patient and Healthcare Provider Perspective on the Treatment Patterns and Patient Satisfaction of Seborrheic Dermatitis in the United States: Results from a National Survey

March 2023

Br J Dermatol

Roflumilast cream for plaque psoriasis with facial/neck & intertriginous involvement (post hoc)

February 2023

J Drugs Dermatol

Safety & efficacy of roflumilast cream 0.15% and 0.05% in atopic dermatitis (phase 2 POC)

November 2022

Am J Clin Dermatol

Pharmacokinetics of roflumilast cream in chronic plaque psoriasis: data from phase I–III studies

November 2022

Am J Clin Dermatol

Effect of roflumilast cream (ARQ-151) on itch & itch-related sleep loss in adults with plaque psoriasis (phase 2b)

Meaningful innovation at a glance.

Download our corporate fact sheet.

Download